Posted: Mar 4, 2013 9:27 AM by Michael Handler; KSBY News
An FDA advisory panel will review two new marketing applications for drugs that have been shown to reduce hot flashes Monday.
Sefelsa was found to reduce the severity and frequency of hot flashes for at least four weeks.
The only approved treatment for menopause is Hormone replacement therapy, which has been linked to an increased risk for breast Cancer and Stroke.
Sefelsa could be one of the first non-hormonal treatment for hot flashes.
PLEASE HELP US MODERATE COMMENTS
Offensive or inappropriate comments are subject to removal. To report a comment, please e-mail us at feedback@ksby.com, and include the name of the story and information on the comment.
Thank you! KSBY.com
Comments